Survodutide
A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and With
Boehringer Ingelheim · Phase 1 · Completed · Enrollment 82
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Part A: BI 456906: Cohort 1 | n/r | n/r | n/r | n/r |
| Part A: BI 456906: Cohort 2 | n/r | n/r | n/r | n/r |
| Part A: BI 456906: Cohort 3 | n/r | n/r | n/r | n/r |
| Part A: BI 456906: Cohort 4 | n/r | n/r | n/r | n/r |
| Part B: BI456906: Cohort 1 | n/r | n/r | n/r | n/r |
| Part B: BI456906: Cohort 2 | n/r | n/r | n/r | n/r |
| Part B: BI456906: Cohort 3 | n/r | n/r | n/r | n/r |
Not shown
- Part A: BI 456906: Cohort 1: endpoint not reported
- Part A: BI 456906: Cohort 2: endpoint not reported
- Part A: BI 456906: Cohort 3: endpoint not reported
- Part A: BI 456906: Cohort 4: endpoint not reported
- Part B: BI456906: Cohort 1: endpoint not reported
- Part B: BI456906: Cohort 2: endpoint not reported
- Part B: BI456906: Cohort 3: endpoint not reported